• 2025
  Léa Deltourbe, Jamie Sugrue, Elizabeth Maloney, Florian Dubois, Anthony Jaquaniello, Jacob Bergstedt, Etienne Patin, Lluis Quintana-Murci, Molly Ingersoll, Darragh Duffy, Steroid hormone levels vary with sex, aging, lifestyle, and genetics, Science Advances , 2025, 11 (13), pp.eadu6094. ⟨10.1126/sciadv.adu6094⟩.
• 2024
  Lakshmikanth T, Consiglio C, Sardh F, Forlin R, Wang J, Tan Z, Barcenilla H, Rodriguez L, Sugrue J, Noori P, Ivanchenko M, Piñero Páez L, Gonzalez L, Habimana Mugabo C, Johnsson A, Ryberg H, Hallgren Å, Pou C, Chen Y, Mikeš J, James A, Dahlqvist P, Wahlberg J, Hagelin A, Holmberg M, Degerblad M, Isaksson M, Duffy D, Kämpe O, Landegren N, Brodin P, Immune system adaptation during gender-affirming testosterone treatment., Nature 2024 Sep; 633(8028): 155-164.
• 2024
  Sugrue JA, Duffy D, Systems vaccinology studies – achievements and future potential., Microbes Infect 2024 Mar; (): 105318.
• 2023
  Sularea VM, Sugrue JA, O'Farrelly C, Innate antiviral immunity and immunometabolism in hepatocytes., Curr Opin Immunol 2023 Feb; 80(): 102267.
• 2022
  Smith N, Possémé C, Bondet V, Sugrue J, Townsend L, Charbit B, Rouilly V, Saint-André V, Dott T, Pozo AR, Yatim N, Schwartz O, Cervantes-Gonzalez M, Ghosn J, Bastard P, Casanova JL, Szwebel TA, Terrier B, Conlon N, O'Farrelly C, Cheallaigh CN, Bourke NM, Duffy D, Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity., Nat Commun 2022 Nov; 13(1): 7254.
• 2022
  Sugrue JA, Posseme C, Tan Z, Pou C, Charbit B, Bondet V, Bourke NM, Brodin P, Duffy D, O'Farrelly C, Enhanced TLR3 responsiveness in hepatitis C virus resistant women from the Irish anti-D cohort., Cell Rep Med 2022 Nov; 3(11): 100804.
• 2022
  Posseme C, Llibre A, Charbit B, Bondet V, Rouilly V, Saint-André V, Boussier J, Bergstedt J, Smith N, Townsend L, Sugrue JA, Ní Cheallaigh C, Conlon N, Rotival M, Kobor MS, Mottez E, Pol S, Patin E, Albert ML, Quintana-Murci L, Duffy D, Early IFNβ secretion determines variable downstream IL-12p70 responses upon TLR4 activation., Cell Rep 2022 Jun; 39(13): 110989.
• 2022
  Sugrue JA, Smith M, Posseme C, Charbit B, , Bourke NM, Duffy D, O'Farrelly C, Rhesus negative males have an enhanced IFNγ-mediated immune response to influenza A virus., Genes Immun 2022 Apr; 23(2): 93-98.
• 2022
  Townsend L, Dyer AH, Naughton A, Imangaliyev S, Dunne J, Kiersey R, Holden D, Mooney A, Leavy D, Ridge K, Sugrue J, Aldoseri M, Kelliher JH, Hennessy M, Byrne D, Browne P, Bacon CL, Doyle C, O'Riordan R, McLaughlin AM, Bannan C, Martin-Loeches I, White A, McLoughlin RM, Bergin C, Bourke NM, O'Farrelly C, Conlon N, Cheallaigh CN, Severe COVID-19 is characterised by inflammation and immature myeloid cells early in disease progression., Heliyon 2022 Apr; 8(4): e09230.
• 2022
  Sugrue JA, O'Farrelly C, Uncovering Resistance to Hepatitis C Virus Infection: Scientific Contributions and Unanswered Questions in the Irish Anti-D Cohort., Pathogens 2022 Feb; 11(3): .
• 2021
  Sugrue JA, Bourke NM, O'Farrelly C, Type I Interferon and the Spectrum of Susceptibility to Viral Infection and Autoimmune Disease: A Shared Genomic Signature., Front Immunol 2021 ; 12(): 757249.
• 2020
  Townsend L, Dyer AH, Jones K, Dunne J, Mooney A, Gaffney F, O'Connor L, Leavy D, O'Brien K, Dowds J, Sugrue JA, Hopkins D, Martin-Loeches I, Ni Cheallaigh C, Nadarajan P, McLaughlin AM, Bourke NM, Bergin C, O'Farrelly C, Bannan C, Conlon N, Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection., PLoS One 2020 ; 15(11): e0240784.
• 2019
  Sugrue J, How I was almost mistaken for a chocolatier., Nature 2019 Apr; 568(7750): 135.
• 2019
  Finucane OM, Sugrue J, Rubio-Araiz A, Guillot-Sestier MV, Lynch MA, The NLRP3 inflammasome modulates glycolysis by increasing PFKFB3 in an IL-1β-dependent manner in macrophages., Sci Rep 2019 Mar; 9(1): 4034.